2 RCCA Oncologists Tell How Immunotherapies Are Increasing Survival in Advanced Melanoma
Immunotherapies and other treatment advances have more than doubled the survival rate for advanced melanoma over the past 20 years,
Category: Melanoma
RCCA physicians in South Jersey discuss melanoma
Share on facebook Share on twitter Share on linkedin Share on email Share on print The New Jersey average of
Cancers Most Likely To Benefit From Targeted Monoclonal Immunotherapy
One of the most effective ways to treat cancer is to harness the power of the body’s own immune system.
Mount Holly oncologist Seth Howard Berk discusses Melanoma trends in Burlington County, Treatment Advances
Dr. Seth Howard Berk, a board-certified hematologist and medical oncologist who practices in Mount Holly, NJ with Regional Cancer Care